MEP4508A - Novel glycolipid adjuvant compositions - Google Patents
Novel glycolipid adjuvant compositionsInfo
- Publication number
- MEP4508A MEP4508A MEP-45/08A MEP4508A MEP4508A ME P4508 A MEP4508 A ME P4508A ME P4508 A MEP4508 A ME P4508A ME P4508 A MEP4508 A ME P4508A
- Authority
- ME
- Montenegro
- Prior art keywords
- adjuvant compositions
- glycolipid adjuvant
- novel glycolipid
- compositions
- novel
- Prior art date
Links
- 229930186217 Glycolipid Natural products 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- HVCOBJNICQPDBP-UHFFFAOYSA-N 3-[3-[3,5-dihydroxy-6-methyl-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxydecanoyloxy]decanoic acid;hydrate Chemical compound O.OC1C(OC(CC(=O)OC(CCCCCCC)CC(O)=O)CCCCCCC)OC(C)C(O)C1OC1C(O)C(O)C(O)C(C)O1 HVCOBJNICQPDBP-UHFFFAOYSA-N 0.000 title 1
- 239000002671 adjuvant Substances 0.000 title 1
- 239000002253 acid Substances 0.000 abstract 1
- 150000007513 acids Chemical class 0.000 abstract 1
- 150000001298 alcohols Chemical class 0.000 abstract 1
- 239000000872 buffer Substances 0.000 abstract 1
- 239000003085 diluting agent Substances 0.000 abstract 1
- 239000002736 nonionic surfactant Substances 0.000 abstract 1
- 239000000243 solution Substances 0.000 abstract 1
- 239000011550 stock solution Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
- A61K39/265—Infectious rhinotracheitis virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/12—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by acids having the group -X-C(=X)-X-, or halides thereof, in which each X means nitrogen, oxygen, sulfur, selenium or tellurium, e.g. carbonic acid, carbamic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/12—Acyclic radicals, not substituted by cyclic structures attached to a nitrogen atom of the saccharide radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16051—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18311—Metapneumovirus, e.g. avian pneumovirus
- C12N2760/18351—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
- C12N2760/18634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
- C12N2760/18651—Methods of production or purification of viral material
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Crystallography & Structural Chemistry (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Peptides Or Proteins (AREA)
- Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US76227906P | 2006-01-26 | 2006-01-26 | |
| US81498406P | 2006-06-20 | 2006-06-20 | |
| PCT/IB2007/000258 WO2007085962A2 (en) | 2006-01-26 | 2007-01-15 | Novel glycolipid adjuvant compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MEP4508A true MEP4508A (en) | 2010-06-10 |
Family
ID=38309580
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MEP-2008-45A ME00045B (me) | 2006-01-26 | 2007-01-15 | Nove kompozicije glikolipidnog adjuvansa |
| MEP-2013-95A ME01545B (me) | 2006-01-26 | 2007-01-15 | Preparati s novim glikolipidnim adjuvansom |
| MEP-45/08A MEP4508A (en) | 2006-01-26 | 2007-01-15 | Novel glycolipid adjuvant compositions |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MEP-2008-45A ME00045B (me) | 2006-01-26 | 2007-01-15 | Nove kompozicije glikolipidnog adjuvansa |
| MEP-2013-95A ME01545B (me) | 2006-01-26 | 2007-01-15 | Preparati s novim glikolipidnim adjuvansom |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US8460679B2 (xx) |
| EP (2) | EP1991266B1 (xx) |
| JP (1) | JP5538725B2 (xx) |
| KR (2) | KR101202553B1 (xx) |
| AR (1) | AR059192A1 (xx) |
| AU (1) | AU2007209104B2 (xx) |
| BR (1) | BRPI0706709B8 (xx) |
| CA (1) | CA2634888C (xx) |
| CY (1) | CY1114310T1 (xx) |
| DK (1) | DK1991266T3 (xx) |
| ES (1) | ES2425576T3 (xx) |
| ME (3) | ME00045B (xx) |
| NO (1) | NO341463B1 (xx) |
| NZ (1) | NZ569375A (xx) |
| PL (1) | PL1991266T3 (xx) |
| PT (1) | PT1991266E (xx) |
| RS (2) | RS20080318A (xx) |
| RU (1) | RU2392965C2 (xx) |
| TW (1) | TWI372631B (xx) |
| WO (1) | WO2007085962A2 (xx) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2040745B1 (en) * | 2006-06-28 | 2012-12-05 | Statens Serum Institut | Expanding the t cell repertoire to include subdominant epitopes by vaccination with antigens delivered as protein fragments or peptide cocktails |
| ES2728949T3 (es) | 2008-06-27 | 2019-10-29 | Zoetis Services Llc | Composiciones adyuvantes novedosas |
| JP5723280B2 (ja) | 2008-10-03 | 2015-05-27 | ノヴァルティス アーゲーＮｏｖａｒｔｉｓ Ａｇ | ウシヘルペスウイルス１型の組成物、ワクチン及び方法 |
| EP2968376B1 (en) * | 2013-03-15 | 2019-06-05 | GlaxoSmithKline Biologicals S.A. | Composition containing buffered aminoalkyl glucosaminide phosphate derivatives and its use for enhancing an immune response |
| US10117921B2 (en) | 2013-09-19 | 2018-11-06 | Zoetis Services Llc | Oil-based adjuvants |
| AU2014354967B2 (en) | 2013-11-26 | 2019-04-11 | Zoetis Services Llc | Compositions for induction of immune response |
| AU2016206525A1 (en) | 2015-01-16 | 2017-07-13 | United States Of America, As Represented By The Secretary Of Agriculture | Foot-and-mouth disease vaccine |
| PT3325015T (pt) * | 2015-07-20 | 2021-07-08 | Zoetis Services Llc | Composições de adjuvante de lipossoma |
| GB201703529D0 (en) | 2017-03-06 | 2017-04-19 | Cambridge Entpr Ltd | Vaccine composition |
| CN110713520B (zh) * | 2019-11-06 | 2021-01-01 | 中国石油天然气股份有限公司 | 油酰基氨基酸-γ-L-谷氨酰-L-半胱氨酰-甘氨酸多肽及其制备与应用 |
| TWI884296B (zh) | 2020-08-11 | 2025-05-21 | 美商碩騰服務公司 | 抗冠狀病毒疫苗 |
| TW202214294A (zh) | 2020-09-30 | 2022-04-16 | 美商碩騰服務公司 | 具有ｈｙａＣ及ｎａｎＰ缺失之新穎多殺性巴斯德氏菌株及疫苗 |
| CN121360223A (zh) | 2024-07-19 | 2026-01-20 | 硕腾服务有限责任公司 | 流感疫苗 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4291019A (en) * | 1979-07-09 | 1981-09-22 | Iowa State University Research Foundation, Inc. | Vaccine for infectious bovine rhinotracheitis |
| DE3213650A1 (de) | 1982-04-14 | 1983-10-27 | Bayer Ag, 5090 Leverkusen | N-glycosylierte carbonsaeureamid-derivate, verfahren zu ihrer herstellung sowie ihre verwendung zur beeinflussung der koerpereigenen abwehr |
| DE3403495A1 (de) | 1983-11-23 | 1985-05-30 | Bayer Ag, 5090 Leverkusen | Phosphorylierte glycosylamide, -harnstoffe, -carbamate und -thiocarbamate, verfahren zu ihrer herstellung sowie ihre verwendung |
| DE3346623A1 (de) | 1983-12-14 | 1985-07-04 | Bayer Ag, 5090 Leverkusen | N-glycosylierte harnstoffe, carbamate und thiocarbamate, verfahren zu ihrer herstellung sowie ihre verwendung |
| DE3521994A1 (de) * | 1985-06-20 | 1987-01-02 | Bayer Ag | N-(2-aminoacylamido-2-desoxy-hexosyl)-amide-, -carbamate und -harnstoffe, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln |
| NZ232740A (en) * | 1989-04-20 | 1992-06-25 | Riker Laboratories Inc | Solution for parenteral administration comprising a 1h-imidazo(4,5-c) quinolin-4-amine derivative, an acid and a tonicity adjuster |
| US6764682B1 (en) | 1994-06-16 | 2004-07-20 | Aventis Pasteur Limited | Adjuvant compositions containing more than one adjuvant |
| US5718904A (en) | 1995-06-02 | 1998-02-17 | American Home Products Corporation | Adjuvants for viral vaccines |
| US6290971B1 (en) * | 1995-06-15 | 2001-09-18 | Aventis Pasteur Limited | Adjuvant compositions comprising a mineral salt and another immunostimulating compound |
| FI109332B (fi) * | 1998-12-17 | 2002-07-15 | Orion Yhtymae Oyj | Toremifeenin liukoisia koostumuksia |
| AU1591402A (en) | 2000-10-02 | 2002-04-15 | Smithkline Beecham Biolog | Vaccine |
-
2007
- 2007-01-15 PT PT77055309T patent/PT1991266E/pt unknown
- 2007-01-15 KR KR1020087018207A patent/KR101202553B1/ko active Active
- 2007-01-15 NZ NZ569375A patent/NZ569375A/en unknown
- 2007-01-15 RS RSP-2008/0318A patent/RS20080318A/sr unknown
- 2007-01-15 ES ES07705530T patent/ES2425576T3/es active Active
- 2007-01-15 BR BRPI0706709A patent/BRPI0706709B8/pt active IP Right Grant
- 2007-01-15 AU AU2007209104A patent/AU2007209104B2/en active Active
- 2007-01-15 EP EP07705530.9A patent/EP1991266B1/en active Active
- 2007-01-15 RU RU2008129203/15A patent/RU2392965C2/ru active
- 2007-01-15 RS RS20130372A patent/RS52930B/sr unknown
- 2007-01-15 CA CA2634888A patent/CA2634888C/en active Active
- 2007-01-15 WO PCT/IB2007/000258 patent/WO2007085962A2/en not_active Ceased
- 2007-01-15 EP EP12165409A patent/EP2481423A1/en not_active Withdrawn
- 2007-01-15 DK DK07705530.9T patent/DK1991266T3/da active
- 2007-01-15 PL PL07705530T patent/PL1991266T3/pl unknown
- 2007-01-15 ME MEP-2008-45A patent/ME00045B/me unknown
- 2007-01-15 ME MEP-2013-95A patent/ME01545B/me unknown
- 2007-01-15 ME MEP-45/08A patent/MEP4508A/xx unknown
- 2007-01-15 KR KR1020117028574A patent/KR20110140140A/ko not_active Ceased
- 2007-01-15 JP JP2008551904A patent/JP5538725B2/ja active Active
- 2007-01-25 AR ARP070100334A patent/AR059192A1/es not_active Application Discontinuation
- 2007-01-25 TW TW096102865A patent/TWI372631B/zh active
- 2007-01-26 US US11/698,335 patent/US8460679B2/en active Active
-
2008
- 2008-08-04 NO NO20083405A patent/NO341463B1/no unknown
-
2013
- 2013-09-03 CY CY20131100756T patent/CY1114310T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MEP4508A (en) | Novel glycolipid adjuvant compositions | |
| EP1882029A4 (en) | Structured surfactant compositions | |
| CL2011003113A1 (es) | Composicion adyuvante acuosa que comprende un agonista de tlr-4 y una saponina y un agente de isotonicidad no ionico; proceso para la preparacion de una composicion inmunogenica. | |
| AR077283A1 (es) | Composiciones detergentes que contienen aminosilicona y metodos para utilizarlas | |
| MX2010013276A (es) | Composicion detergente que comprende una variante de una xiloglucanasa de la familia 44. | |
| MX2015011298A (es) | Formulaciones acuosas, su fabricacion, y su uso en la limpieza de superficies duras. | |
| MX2013010149A (es) | Desinfectante de amplio espectro. | |
| AR074270A1 (es) | Composicion de champu concentrada | |
| MX2013006469A (es) | Composicion liquida de limpieza que contiene alcoholes grasos de cadena larga. | |
| WO2010108756A3 (de) | Wässrige haar- und hautreinigungszusammensetzungen | |
| MY176046A (en) | Composition and method | |
| DOP2011000329A (es) | Preparacion de solido | |
| AR080796A1 (es) | Composiciones acuosas que comprenden un acil-isetionato para el cuidado personal. | |
| MX2008001938A (es) | Composiciones que contienen alcoxilatos de alcohol graso. | |
| BR112012016319A2 (pt) | sólido, método para produzir um sólido, e, formulação sólida de detergente ou limpador | |
| AR074271A1 (es) | Composicion de champu concentrada | |
| DOP2011000025A (es) | Metodos para entregar una frangancia | |
| AR077524A1 (es) | Agentes quelantes y uso de los mismos | |
| UA90569C2 (ru) | Композиция гликолипидного адьюванта (варианты) и способ ее получения | |
| PE20131219A1 (es) | Metodo para la preparacion de acido montelukast en un medio liquido ionico | |
| ATE546513T1 (de) | Saure zusammensetzung auf basis einer tensidmischung | |
| BRPI0607264A2 (pt) | uso de um composto de amÈnio quaternário como um hidrótropo e uma composição contendo o composto de amÈnio quartenário | |
| RU2009137938A (ru) | Порошок титаната калия | |
| MY159304A (en) | Detergent composition | |
| BRPI0607269A2 (pt) | protetores de cisalhamento para colheita por microfiltragem |